Beckman Coulter Life Sciences is taking actions in the best interests of our associates, customers, and business partners as we navigate the growing threats of the 2019 Novel Coronavirus disease (COVID-19). Learn more
ESCCA 2016 presentation provides an overview of flow cytometry immunophenotyping and the use of ClearLab IVD antibody cocktails in diagnosing hematologic malignancies. Includes summary of a feasible two-step approach with a screening tube and related diagnostic results.
Ops. La pagina che volevate non è stata trovata, quindi vi abbiamo portato a qualcosa di simile. Se ancora non riuscite a trovare ciò che desiderate, provate a fare una ricerca nel nostro sito.
